POSTER SESSION VI
Wednesday, March 5, 2008   —  1:00 PM - 4:00 PM
Convention Center Exhibit Hall A


Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...




LIVER & PANCREAS PATHOLOGY



Poster#Title and AuthorsItinerary
Planner
192 Histologic Findings in Post-Reperfusion and Follow-Up Biopsies in Liver Transplant Patients: Is There Any Correlation? (1433)
M Raoufi, C Ma, A Ormsby, V Shah, K Brown, M Sherbondy, D Moonka, M Abouljoud - Henry Ford Hospital, Detroit, MI
Add
193 Clinicopathologic Features of CMV Hepatitis in Liver Transplant Patients (1432)
SH Ra, J Hong, CR Lassman - David Geffen School of Medicine at UCLA, Los Angeles, CA
Add
194 Presence and Diagnostic Significance of CD21+ Follicular Dendritic Cells in Liver Biopsies with Hepatitis C and Acute Allograft Rejection (1404)
M Krishna, RE Nakhleh, A Khoor - Mayo Clinic, Jacksonville, FL
Add
195 Does Knowledge of Immune Functioning Aid in the Interpretation of Liver Allograft Biopsies in Patients Status Post Liver Transplantation for Viral Hepatitis C? (1436)
TC Rubinas, ES Dellon, G Henel - UNC Chapel Hill, Chapel Hill, NC
Add
196 Increased Frequency of Central Venulitis after Liver Transplantation for Primary Biliary Cirrhosis (1453)
CO Zein, B Eghtesad, CM Miller, AJ McCullough, LM Yerian - Case Western Reserve University; Cleveland Clinic, Cleveland, OH
Add
197 Degree of Plasma Cell Infiltration in Liver Explants of Patients Undergoing Transplantation for HCV Is Predictive of the Development of De Novo Autoimmune Hepatitis (1449)
SC Ward, TD Schiano, SN Thung, MI Fiel - Mount Sinai School of Medicine, New York, NY
Add
198 Marked Iron Accumulation in Liver Explants: A Risk Factor for Cardiac Failure Even in the Absence of Major Gene Defects of Hereditary Hemochromatosis (1386)
H Fenton, M Torbenson, P Vivekanandan, L Ferrell - UCSF, San Francisco, CA; Johns Hopkins, Baltimore, MD
Add
199 Under-Diagnosis of Chronic Hepatic Allograft Rejection in Routine Needle Biopsies Is More Due to Non-Recognition of Ductopenia Than Inadequate Sampling (1419)
M McIntire, D Giusto, S Jakate - Rush University Medical Center, Chicago, IL
Add
200 Circulating Microparticles as a Possible Diagnostic Marker in Liver Transplant Patients (1368)
SV Brodsky, ME Facciuto, D Heydt, HK Islam, J Chen, M Kajstura, M Aguero-Rosenfeld - New York Medical College, Valhalla, NY
Add
201 Smad4 Overexpression in Mixed Hepatocellular-Cholangiocarcinoma Confirms Its Close Relation to Hepatocellular Carcinoma (1451)
R Xu, S Ward, A Suriawinata, S Thung - The Mount Sinai Medical Center, New York, NY; Dartmouth-Hitchcock Medical Center, Lebanon, NH
Add
202 Proposal of Progression Model for Intrahepatic Cholangiocarcinoma: Clinicopathologic Differences between Hilar Type and Peripheral Type (1359)
S Aishima, Y Nishihara, K Taguchi, M Tsuneyoshi - Hamanomachi Hospital; Kyushu University; National Kyushu Cancer Center, Fukuoka, Japan
Add
203 Morphoproteomic Profile of Signal Transduction Pathways of Convergence in Cholangiocarcinoma (1366)
S Billah, W Li, B Zhao, RE Brown - The University of Texas Medical School, Houston, TX
Add
204 Quantitative Analysis of CpG Island Hypermethylation in Extrahepatic Cholangiocarcinoma, Biliary Dysplasia and Normal Bile Ducts (1400)
BH Kim, NY Cho, EJ Yoo, JJ Jang, GH Kang - Seoul National University College of Medicine; Cancer Research Institute, Seoul National University, Seoul, Republic of Korea
Add
205 Immunohistochemical and FISH Analysis of EGFR and HER-2/neu Status in Adenocarcinomas of the Biliary Tree and Gallbladder (1439)
N Shafizadeh, JP Grenert, S Kakar - VA/UCSF, San Francisco, CA
Add
206 Expression of p16 in Gallbladder Adenocarcinoma (1377)
JH Choi, AR Kim, JM Kim - Yeungnam University College of Medicine, Daegu, Korea; Yeungnam University College of Medicine, Daegu, Kuwait
Add
207 Primary Gallbladder Sarcoma: 18 New Cases (1360)
W Al-Daraji, HR Makhlouf, M Miettinen, EA Montgomery, ZD Goodman, JC Fanburg-Smith - Armed Forces Institute of Pathology, Washington, DC; Johns Hopkins Hospital, Baltimore, MD
Add
208 Epstein-Barr Virus Is Not Responsible for the Inflammatory Pseudotumor like Morphology and Venulitis Associated with Lymphoplasmacytic Sclerosing Pancreatitis (1376)
Z-M Chen, M Guler, JR Scudiere, RH Hruban - Johns Hopkins Medical Institutions, Baltimore, MD
Add
209 Regressing Lymphoplasmacytic Sclerosing Pancreatitis (1423)
K Notohara, TC Smyrk, T Nakazawa, M Mino-Kenudson - Kurashiki Central Hospital, Kurashiki, Japan; Mayo Clinic, Rochester, MN; Nagoya City University Graduate School of Medical Science, Nagoya, Japan; Massachusetts General Hospital, Boston, MA
Add
210 Lipomatous Hypertrophy of the Pancreas: A Clinicopathologically Distinct Entity (1361)
D Altinel, JM Sarmiento, D Martin, MJ Jacobs, D Kooby, NV Adsay - Emory University, Atlanta; Province Hosp, Southfield
Add
211 Divergent Activation of the DNA Damage Response in Ductal and Endocrine Neoplastic Progression in the Pancreas (1438)
AL Sengupta, T Pasha, KS Gustafson, EE Furth - University of Pennsylvania Medical Center, Philadelphia, PA; Johns Hopkins University, Baltimore, MD
Add
212 Pancreatic Intraepithelial Neoplasia Is Common at the Periphery of and Can Be Present within Serous Cystadenomas (1443)
N Suh, D Jain, R Salem, ME Robert - Yale University, New Haven, CT
Add
213 The Grade, Extent, and Duct Involvement of PanIN Associated with Pancreatic Ductal Adenocarcinoma and IPMN Differ from Those Associated with Non-Ductal Pancreatic Tumors and Non-Turmorous Lesions (1435)
C Recavarren, L Zhang, DM Labow, M Wong, R Xu - The Mount Sinai Medical Center, New York, NY
Add
214 Expression of von Hipple-Lindau Gene Product (pVHL) and S100P in Cystic Neoplasms of the Pancreas - With an Implication for Their Roles in Tumorigenesis (1410)
F Lin, J Shi, J Zhang, H Liu, RE Brown, HL Wang - Geisinger Medical Center, Danville, PA; Mayo Clinic, Rochester, MN; University of Texas at Houston, Houston, TX; Cedars-Sinai Medical Center, Los Angeles, CA
Add
215 Molecular Alterations in Morphologic Subtypes of Pancreatic Intraductal Papillary Mucinous Neoplasm Are Distinct from Those Seen in Pancreatic Ductal Adenocarcinoma (1391)
M Hsu, A Srivastava, JL Hornick, J Fukuoka, AJ Iafrate, GY Lauwers, M Mino-Kenudson - Massachusetts General Hospital, Boston, MA; Dartmouth Hitchcock Medical Center, Lebanon, NH; Brigham & Women's Hospital, Boston, MA; Toyama Medical University, Toyama, Japan
Add
216 Staining for HMGA2 in Serous and Mucinous Cystic Pancreatic Lesions (1447)
WS Twaddell, C DiMaio, P Stevens, T Wang, JM D'Armiento, HE Remotti - Columbia University Medical Center, New York, NY
Add
217 Tumor Infiltrating Neutrophils in Pancreatic Neoplasia: Biologic Implications (1445)
D Thirabanjasak, O Basturk, R Hruban, DS Klimstra, D Altinel, JD Cheng, NV Adsay - WSU, Detroit; NYU, New York; Johns Hopkins Univ., Baltimore; MSKCC, New York; Emory Univ., Altanta
Add
218 Global Histone Modifications as Markers of Pancreatic Ductal Adenocarcinoma Prognosis (1413)
Y Lu, L Kim, B Frederick, M Zhang, J Liao, M Talamonti, D Bentrem, SM Rao, GY Yang - Feinberg School of Medicine, Northwestern University, Chicago, IL
Add
219 Evaluation of Expression and Activation Status of NF-kB in Pancreatic Ductal Carcinoma (1425)
M Othman, O Basturk, F Sarkar, V Adsay, E Levi - Harper University Hospital, Wayne State University, Detroit; New York University Medical Center, New York; Emory University Hospital, Atlanta; John D. Dingell VAMC, Detroit
Add
220 Fibronectin Receptor: A Unique Malignant Biomarker of Pancreatic Carcinoma (1401)
L Kim, M Zhang, J Liao, M Talamonti, D Bentrem, SM Rao, GY Yang - Northwestern Memorial Hospital, Chicago, IL
Add
221 High Frequency of Epidermal Growth Factor Receptor Expression in Pancreaticobiliary Adenocarcinomas (1414)
MT Mac, F Chung, BL Balzer, HL Wang - Cedars-Sinai Medical Center, Los Angeles, CA
Add
222 Lessons Learned from 5 Year Survivors of Pancreatic Adenocarcinoma: A Critical Look at the AJCC Staging System (1402)
AF Koreishi, CR Ferrone, GY Lauwers, V Deshpande - Massachusetts General Hospital, Boston, MA
Add
223 Superior Mesenteric Vein/Portal Vein Invasion Is Associated with Poor Survival in Patients with Stage II Pancreatic Ductal Carcinoma Who Received Pre-Operative Chemoradiation (1454)
L Peng, A Rashid, DB Evans, GR Varadhachary, JE Lee, JB Fleming, PWT Pisters, JL Abbruzzese, RA Wolff, H Wang - UT MD Anderson Cancer Center, Houston, TX
Add
224 Mist1 Expression in Acinar Carcinomas and Intraductal Oncocytic Papillary Neoplasms of the Pancreas (1375)
Z-M Chen, D DiRenzo, G Shi, M Guler, D Klimstra, V Adsay, SF Konieczny, RH Hruban - Johns Hopkins Medical Institutions, Baltimore, MD; Memorial Sloan-Kettering Cancer Center, New York, NY; Wayne State Univ., School of Medicine, Detroit, MI; Purdue University, West Lafayette, IN
Add
225 Mismatch Repair Proteins in Pancreatic Endocrine Neoplasms (1393)
M Hsu, A Srivastava, M Mino-Kenudson, V Deshpande, GY Lauwers - Massachusetts General Hospital, Boston, MA; Dartmouth Hitchcock Medical Center, Lebanon, NH
Add
226 Renal Cell Carcinoma Metastatic to the Pancreas: A Clinicopathologic and Immunohistochemical Study of 13 Cases (1389)
S Hafezi, V Maksymov, Z Ghorab, C Rowsell, S Hanna, C Law, MA Khalifa - University of Toronto, Toronto, Canada; Memorial University, Newfoundland, Canada
Add